<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Cleveland University Hospitals Center Begins Investigational Antibody Trials for COVID-19
Image Overlay - Cleveland University Hospitals Center Begins Investigational Antibody Trials for COVID-19

Cleveland University Hospitals Center Begins Investigational Antibody Trials for COVID-19

Cleveland University Hospitals Center Begins Investigational Antibody Trials for COVID-19

University Hospitals in Cleveland, Ohio is the latest facility to participate in novel clinical trials to combat COVID-19. The site will begin by testing an experimental monoclonal antibody treatment called LY-CoV555. To participate, enrollees must have tested positive for SARS-CoV-2 infection within seven days and started experiencing symptoms within ten days of enrolling in the study, though not requiring hospitalization. Regardless of how experimental and valuable the clinical trial substance, Yourway’s expansive transportation fleet, global regulatory expertise and dedicated project managers, make us the only truly integrated provider able to serve the full breadth of your drug product distribution needs.

Back to Index
Media

Upcoming Events

Clinical Trial Supply East Coast 2022

October 19-20, 2022
King of Prussia, PA, USA

Media

Articles

Helping Sponsors Navigate Complex Ancillary Supply Sourcing Challenges with Integrated Services

Open chat
Come chat with us!
Hello! How can I help you?